Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus

AIM: To characterize the pharmacokinetic and pharmacodynamic properties of dasiglucagon, a novel, stable and liquid formulated glucagon analogue, during hypoglycaemic and euglycaemic conditions in adult patients with type 1 diabetes mellitus. RESEARCH DESIGN AND METHODS: In this randomized double‐bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hövelmann, Ulrike, Olsen, Minna Brændholt, Mouritzen, Ulrik, Lamers, Daniela, Kronshage, Birgit, Heise, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587565/
https://www.ncbi.nlm.nih.gov/pubmed/30350477
http://dx.doi.org/10.1111/dom.13562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587565/
https://www.ncbi.nlm.nih.gov/pubmed/30350477
http://dx.doi.org/10.1111/dom.13562

Ejemplares similares